EFFICACY OF TARGET THERAPY WITH CRIZOTINIB IN A PATIENT WITH ALK-POSITIVE ADVANCED GASTRIC CANCER
Although many currently known molecular targets are characterized by organ specificity, they can be found in various types of tumors. Molecular diagnostic techniques can be used to help select patients who are most likely to benefit from target therapy. Case presentation. We describe the case of a 3...
Saved in:
Main Authors: | A. A. Paichadze, L. V. Bolotina, E. Y. Karpenko, T. V. Ustinova, A. L. Kornietskaya, A. D. Kaprin, A. A. Fedenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2020-03-01
|
Series: | Сибирский онкологический журнал |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/1334 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evolution of drug therapy in patients with resectable gastric and esophageal‑gastric junction cancer
by: M. V. Sedova, et al.
Published: (2023-06-01) -
THE ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED GASTRIC CANCER
by: A. A. Bobryshev, et al.
Published: (2021-03-01) -
OUR EXPERIENCE OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PATIENTS WITH ADVANCED GASTRIC CANCER
by: A. D. Kaprin, et al.
Published: (2016-01-01) -
ADJUVANT TREATMENT OF GASTRIC CANCER
by: D. T. Arybzhanov, et al.
Published: (2017-02-01) -
The Screening of Aptamer-Gastric Cancer for Targeting Gastric Cancer Cells
by: Xixi Xiao, et al.
Published: (2025-06-01)